TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT05386615: Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine Fibroids

Sponsor: InSightec · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 200 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$9,395,600

Rescue Site Savings

+$6,208,400

Unlock Full NCT05386615 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT05386615 Rescue Dossier →